SC
EVH icon

ShearLink Capital’s Evolent Health EVH Stock Holding History

ShearLink Capital’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-116,972
Closed -$2.28M – 17
2015
Q2 		$2.28M Buy
+116,972
New +$2.18M 1.03% 20

Other funds holding EVH

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ShearLink Capital's EVH Position: Q3 2015 in Review

ShearLink Capital sold out of Evolent Health (EVH) in Q3 2015, closing a stake of 116,972 shares — an estimated $2.28M sold.

ShearLink Capital first reported a position in EVH in Q2 2015 and held it in 1 quarter. The position peaked at $2.28M in Q2 2015. 69 funds tracked by Wall St. Rank hold EVH as of Q3 2015.

  • ShearLink Capital reported no remaining Evolent Health position as of Q3 2015 after selling out during the quarter.
  • ShearLink Capital sold 116,972 Evolent Health shares in Q3 2015, an estimated $2.28M.
  • ShearLink Capital first reported a position in Evolent Health in Q2 2015 and held it in 1 quarter.
  • ShearLink Capital's Evolent Health position peaked at $2.28M in Q2 2015.
  • 69 funds tracked by Wall St. Rank held Evolent Health as of Q3 2015.

Based on ShearLink Capital's 13F filing for Q3 2015, filed 13 Nov 2015.